Allarity Therapeutics annual free cash flow
2020
2022
2023
2024
2025
Allarity Therapeutics Free Cash Flow (FCF) History (ALLR)
Allarity Therapeutics reported −$14.8M in free cash flow for fiscal 2025, an increase of $2.8M from the previous fiscal year, with a free cash flow margin of −4633.75%.
View full Allarity Therapeutics company overviewAllarity Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$14.8M | $2.8M | — | −4633.75% |
| 2024 | 2024-12-31 | −$17.6M | −$4.9M | — | — |
| 2023 | 2023-12-31 | −$12.7M | $4.1M | — | — |
| 2022 | 2022-12-31 | −$16.8M | −$9.6M | — | — |
| 2020 | 2020-12-31 | −$7.3M | — | — | — |
Allarity Therapeutics quarterly free cash flow
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$2.6M | — | — | — |
| Q1 2026 | 2026-03-31 | −$4.6M | — | — | −18228.00% |
| Q2 2025 | 2025-06-30 | −$5.5M | — | — | — |
| Q1 2025 | 2025-03-31 | −$2.7M | — | — | — |
Allarity Therapeutics free cash flow growth trends
Allarity Therapeutics's latest reported quarter, Q2 2026, generated −$2.6M in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Allarity Therapeutics filings at SEC.gov ↗